WallStreetZenWallStreetZen

NASDAQ: ATXS
Astria Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ATXS earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$72.9M
Current Profit Margin
0%

ATXS Return on Equity

Current Company
-34.7%
Current Industry
-63.5%
Current Market
188%
ATXS's Return on Equity (-34.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ATXS announces earnings.

ATXS Return on Assets

Current Company
-33.4%
Current Industry
2.9%
ATXS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ATXS Return on Capital Employed

Current Company
-29.98%
Current Industry
19.5%
ATXS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ATXS vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ATXS$0.00-$72.89M-$72.89MN/AN/A
ABUS$18.14M-$70.99M-$72.85M+25.00%N/A
ALLO$95.00k-$313.07M-$327.27M-97.11%N/A
PROK$0.00-$25.61M-$35.47MN/AN/A
ALEC$97.06M-$116.33M-$130.39M+28.52%N/A
View Top Biotech Stocks

ATXS earnings dates

Next earnings date
Jun 5, 2024

Astria Therapeutics Earnings & Revenue FAQ

What were ATXS's earnings last quarter?

On Invalid Date, Astria Therapeutics (NASDAQ: ATXS) reported Q4 2023 earnings per share (EPS) of -$0.94, up 46.88% year over year. Total Astria Therapeutics earnings for the quarter were -$31.41 million. In the same quarter last year, Astria Therapeutics's earnings per share (EPS) was -$0.64.

If you're new to stock investing, here's how to buy Astria Therapeutics stock.

What was ATXS's earnings growth in the past year?

As of Q2 2024, Astria Therapeutics's earnings has grown year over year. Astria Therapeutics's earnings in the past year totalled -$72.89 million.

What is ATXS's earnings date?

Astria Therapeutics's earnings date is Invalid Date. Add ATXS to your watchlist to be reminded of ATXS's next earnings announcement.

What was ATXS's revenue last quarter?

On Invalid Date, Astria Therapeutics (NASDAQ: ATXS) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Astria Therapeutics's revenue was $0.00.

What was ATXS's revenue growth in the past year?

As of Q2 2024, Astria Therapeutics's revenue has grown null year over year. Astria Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.